XTX Topco Ltd Buys New Shares in HealthEquity, Inc. $HQY

XTX Topco Ltd bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the second quarter, Holdings Channel reports. The fund bought 19,304 shares of the company’s stock, valued at approximately $2,022,000.

Several other hedge funds have also recently added to or reduced their stakes in HQY. Nisa Investment Advisors LLC lifted its position in shares of HealthEquity by 2.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 3,787 shares of the company’s stock valued at $397,000 after acquiring an additional 108 shares during the last quarter. Ieq Capital LLC raised its position in shares of HealthEquity by 4.4% during the first quarter. Ieq Capital LLC now owns 2,945 shares of the company’s stock worth $260,000 after purchasing an additional 123 shares during the period. Coldstream Capital Management Inc. lifted its holdings in shares of HealthEquity by 7.3% during the second quarter. Coldstream Capital Management Inc. now owns 2,027 shares of the company’s stock valued at $212,000 after purchasing an additional 138 shares during the last quarter. Sheets Smith Wealth Management lifted its holdings in shares of HealthEquity by 1.9% during the second quarter. Sheets Smith Wealth Management now owns 8,419 shares of the company’s stock valued at $882,000 after purchasing an additional 157 shares during the last quarter. Finally, Nordea Investment Management AB boosted its position in shares of HealthEquity by 0.3% in the 2nd quarter. Nordea Investment Management AB now owns 59,732 shares of the company’s stock valued at $6,319,000 after purchasing an additional 164 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $104.99 on Friday. The business’s 50-day moving average is $95.89 and its 200-day moving average is $96.78. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market capitalization of $9.05 billion, a price-to-earnings ratio of 63.63, a P/E/G ratio of 1.36 and a beta of 0.47. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $325.80 million during the quarter, compared to analysts’ expectations of $320.68 million. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of HealthEquity stock in a transaction on Thursday, November 20th. The shares were sold at an average price of $104.56, for a total transaction of $156,840.00. Following the completion of the sale, the executive vice president owned 75,479 shares of the company’s stock, valued at $7,892,084.24. This trade represents a 1.95% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 1,781 shares of the company’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the transaction, the executive vice president directly owned 49,795 shares in the company, valued at $4,392,416.95. This trade represents a 3.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 10,781 shares of company stock valued at $1,016,707 in the last three months. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HQY shares. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Royal Bank Of Canada lifted their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. JPMorgan Chase & Co. boosted their price target on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a report on Wednesday, September 3rd. Jefferies Financial Group upped their price target on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Finally, KeyCorp lowered their price objective on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and an average target price of $119.00.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.